Skip to content
← Back to this collection

PUBLICATIONS · 38078508

Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2024 Jan 25
First author
Munir T

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 May 2;390(17):1633-1634. doi: 10.1056/NEJMc2402472.
    note
    Source null
    related pmid
    38692303
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 May 2;390(17):1634-1635. doi: 10.1056/NEJMc2402472.
    note
    Source null
    related pmid
    38692304
    relationship
    Comment in

Authors and identifiers

  1. name
    Munir T
    type
    Author
  2. name
    Cairns DA
    type
    Author
  3. name
    Bloor A
    type
    Author
  4. name
    Allsup D
    type
    Author
  5. name
    Cwynarski K
    type
    Author
  6. name
    Pettitt A
    type
    Author
  7. name
    Paneesha S
    type
    Author
  8. name
    Fox CP
    type
    Author
  9. name
    Eyre TA
    type
    Author
  10. name
    Forconi F
    type
    Author
  11. name
    Elmusharaf N
    type
    Author
  12. name
    Kennedy B
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Munir T
    type
    Author
  2. name
    Cairns DA
    type
    Author
  3. name
    Bloor A
    type
    Author
  4. name
    Allsup D
    type
    Author
  5. name
    Cwynarski K
    type
    Author
  6. name
    Pettitt A
    type
    Author
  7. name
    Paneesha S
    type
    Author
  8. name
    Fox CP
    type
    Author
  9. name
    Eyre TA
    type
    Author
  10. name
    Forconi F
    type
    Author
  11. name
    Elmusharaf N
    type
    Author
  12. name
    Kennedy B
    type
    Author
bibliography ids
  1. nci-bib-aa459dffad18e3fa3787ca5f
book metadata
content sha256
04e3c36069e7c96251a67e4124f8b908c0cdbc70cb1208185852f6b0f2eea982
document type
citation
dois
  1. 10.1056/NEJMoa2310063
electronic publication date
display
2023 Dec 10
precision
day
year
2023
evidence scope
bibliographic_metadata_only
id
pubmed:38078508
immutable id
pubmed:38078508@04e3c36069e7c96251a67e4124f8b908c0cdbc70cb1208185852f6b0f2eea982
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
326-337
volume
390
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2024 May 2;390(17):1633-1634. doi: 10.1056/NEJMc2402472.
    note
    Source null
    related pmid
    38692303
    relationship
    Comment in
  2. citation
    N Engl J Med. 2024 May 2;390(17):1634-1635. doi: 10.1056/NEJMc2402472.
    note
    Source null
    related pmid
    38692304
    relationship
    Comment in
outcomes validated
false
pmid
38078508
provenance
batch id
6d213eecf21b6b7867cb
provider
NCBI PubMed ESummary
record sha256
e3f6581ca1eb14649507d6d984881310e3aaa3f1e23ede70daf9f900846e1e04
response sha256
684f894a21d8f5f78a3bd0acd8ee4215ff94144487c53dab1056650ee8d6751d
retrieved at
2026-09-09T23:48:19.049083+00:00
publication date
display
2024 Jan 25
precision
day
year
2024
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Adaptive Clinical Trial
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/38078508/
title
Chronic Lymphocytic Leukemia Therapy Guided by Measurable Residual Disease.

Preserved source evidence · Not medical advice